RxDoctor Payments Data

Amber Corneillie, PA

Surgical · Kalamazoo, MINPI 1033187265

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations.

$1,445in general payments, 2019–2025

Across 46 payments — averaging $31.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$157
  • UCB, Inc.$132
  • Amgen$124
  • Regeneron Healthcare Solutions, Inc.$112
  • Sun Pharmaceutical Industries Inc.$111
  • Lilly USA, LLC$101
  • plus $709 from 12 others

What the payments were for

  • Food & beverage$1,445100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,445 in reported general payments places this provider in the 80th percentile of 229 surgical providers in Michigan.

See all surgical providers in Michigan

Medicare billing

Part B allowed, 2024
$113,027
Medicare patients
408
Services billed
2,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Taltz AutoinjectorIxekizumab17$150,698
Azelaic Acid45$6,083
Fluorouracil56$3,776
Clobetasol Propionate97$3,392
Metronidazole63$3,371
Ketoconazole142$2,182
Triamcinolone Acetonide205$2,031
Hydrocortisone127$1,199
Clindamycin Phosphate26$1,114
Betamethasone Dipropionate25$1,037
Tretinoin13$820
Doxycycline Monohydrate34$687
Fluocinonide12$366
Econazole Nitrate13$325
Cephalexin77$298

Paid to pharmacies, not to this prescriber.

Other surgical in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →